Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Durvalumab 1500 / Gemcitabine 1250 / Cisplatin 75, Non-Small Cell Lung Cancer, neoadjuvant, Cycle 1-4

Protocol-ID: 2493 V1.0 (Mini), DURV1500/GEMC1250/CISP75, NSCLC, neoadj., C1-4

Indication(s)

  • Lung Carcinoma, Non-Small Cell (Squamous Cell Carcinoma); ICD-10 C34.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 15.11.2023